Koyfin Home > Directory > Health Care > Ironwood Pharmaceuti > EBIT

Ironwood Pharmaceuti EBIT Chart (IRWD)

Ironwood Pharmaceuti annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Ironwood Pharmaceuti EBIT for the quarter ending June 06, 2020 was $33m a -100.90% decrease of -33m year over year
  • Ironwood Pharmaceuti EBIT for the last 12 months ending June 06, 2020 was $162m a 34.96% increase of 57m year over year
  • Ironwood Pharmaceuti Annual EBIT for 2019 was $123m a 110.53% increase of 136m from 2018
  • Ironwood Pharmaceuti Annual EBIT for 2018 was $-13m a -251.94% increase of 33m from 2017
  • Ironwood Pharmaceuti Annual EBIT for 2017 was $-46m a 8.16% decrease of -4m from 2016
Other Income Statement Metrics:
  • Ironwood Pharmaceuti EBITDA for the quarter ending December 12, 2018 was $9m a 440.04% increase of 41m year over year
  • Ironwood Pharmaceuti Net Income for the quarter ending December 12, 2018 was $-15m a -178.47% increase of 28m year over year
  • Ironwood Pharmaceuti Total Revenue for the quarter ending September 09, 2018 was $66m a -43.42% decrease of -29m year over year
View Chart On Koyfin

Quarterly IRWD EBIT Data

06/2020$33m
03/2020$13m
12/2019$52m
09/2019$66m
06/2019$20m
03/2019$-13m
12/2018$33m
09/2018$-18m
06/2018$-11m
03/2018$-33m

Annual IRWD EBIT Data

2019$123m
2018$-13m
2017$-46m
2016$-42m
2015$-102m
2014$-165m
2013$-252m
2012$-73m
2011$-66m
2010$-61m